Cargando…
Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354450/ https://www.ncbi.nlm.nih.gov/pubmed/35935628 http://dx.doi.org/10.3389/fcvm.2022.916695 |
| _version_ | 1784763074844033024 |
|---|---|
| author | Shah, Aditya Sharma, Kamal Rawal, Shalin Sisodia, Rhea Bhatt, Parjanya Christian, Cleris Konat, Ashwati |
| author_facet | Shah, Aditya Sharma, Kamal Rawal, Shalin Sisodia, Rhea Bhatt, Parjanya Christian, Cleris Konat, Ashwati |
| author_sort | Shah, Aditya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9354450 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93544502022-08-06 Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease Shah, Aditya Sharma, Kamal Rawal, Shalin Sisodia, Rhea Bhatt, Parjanya Christian, Cleris Konat, Ashwati Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9354450/ /pubmed/35935628 http://dx.doi.org/10.3389/fcvm.2022.916695 Text en Copyright © 2022 Shah, Sharma, Rawal, Sisodia, Bhatt, Christian and Konat. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Cardiovascular Medicine Shah, Aditya Sharma, Kamal Rawal, Shalin Sisodia, Rhea Bhatt, Parjanya Christian, Cleris Konat, Ashwati Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease |
| title | Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease |
| title_full | Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease |
| title_fullStr | Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease |
| title_full_unstemmed | Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease |
| title_short | Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease |
| title_sort | commentary: beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease |
| topic | Cardiovascular Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354450/ https://www.ncbi.nlm.nih.gov/pubmed/35935628 http://dx.doi.org/10.3389/fcvm.2022.916695 |
| work_keys_str_mv | AT shahaditya commentarybeyond10yearriskacosteffectivenessanalysisofstatinsfortheprimarypreventionofcardiovasculardisease AT sharmakamal commentarybeyond10yearriskacosteffectivenessanalysisofstatinsfortheprimarypreventionofcardiovasculardisease AT rawalshalin commentarybeyond10yearriskacosteffectivenessanalysisofstatinsfortheprimarypreventionofcardiovasculardisease AT sisodiarhea commentarybeyond10yearriskacosteffectivenessanalysisofstatinsfortheprimarypreventionofcardiovasculardisease AT bhattparjanya commentarybeyond10yearriskacosteffectivenessanalysisofstatinsfortheprimarypreventionofcardiovasculardisease AT christiancleris commentarybeyond10yearriskacosteffectivenessanalysisofstatinsfortheprimarypreventionofcardiovasculardisease AT konatashwati commentarybeyond10yearriskacosteffectivenessanalysisofstatinsfortheprimarypreventionofcardiovasculardisease |